Bayerische Patentallianz

What Bayerische Patentallianz does

Bayerische Patentallianz GmbH, also known as BayPAT, is a Munich-based private company founded in 2007 by Universität Bayern e.V. and Hochschule Bayern e.V. to commercialize inventions from Bavarian universities and universities of applied sciences. It operates as a central technology transfer agency for Bavarian universities, university hospitals and universities of applied sciences, with recent source data citing 33 research institutions and more than 25,000 associated researchers. Its served market is two-sided: academic inventors and research institutions that need invention assessment, patent protection and commercialization support, and industry buyers, licensees and spin-offs that seek access to university-originated intellectual property.

BayPAT does not develop a proprietary software or hardware technology platform. Its core assets are technology-transfer processes and managed intellectual-property portfolios across life sciences and physical sciences, including approximately 1,100 patents granted since 2007 and about 150 active technology offers. Services include invention evaluation, patent prosecution, portfolio management, market analysis, commercialization strategy, licensing and sale negotiation, startup support, and support for WIPANO applicants; technology domains include biotechnology, chemistry, medical engineering, oncology, radiopharmaceuticals, energy, automotive, electrical engineering, materials and mechanical engineering.

The business model is based on IP licensing and royalty revenue, upfront and milestone payments under license agreements, patent sale or transfer revenue, and technology-transfer service fees or public/service support linked to the Bavarian innovation ecosystem. Pricing is not publicly disclosed and commercial terms are negotiated case by case rather than through a published subscription or standardized fee schedule. Go-to-market is direct and relationship-led, using BayPAT's licensing managers, university network and BayFIA-related ecosystem, with named counterparties including Kyocera, Linde, Evonik, E.ON Energy Projects, Scintomics, Cycuria, Orbem, MODAG, NavVis and Bitflux.

Name

Bayerische Patentallianz

Legal name

Bayerische Patentallianz GmbH

Website

https://baypat.de

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Bayerische Patentallianz is a Munich-based technology transfer office that manages patents, licensing and commercialization for Bavarian universities and research institutes, connecting academic inventions in life sciences and physical sciences with industry buyers, licensees and spin-offs.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Lessors of Nonfinancial Intangible Assets (except Copyrighted Works) (533)

SIC

Patent Owners & Lessors (6794)

akta.pro primary industry

IP Licensing, Transactions & Technology Transfer (BPAHAMAF)

Keywords

• Technology transfer services
• Intellectual property licensing
• Patent commercialization
• University technology transfer
• IP management services

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. IP Licensing and Royalty Revenue: BayPAT generates revenue through licensing university inventions to industry partners, including exclusive and non-exclusive license agreements across fields such as biotechnology, chemistry, medical engineering, physics, automotive, energy, IT/communications, and mechanical engineering. Revenue is derived from upfront payments, milestone payments, and ongoing royalties under license contracts negotiated with companies such as Scintomics, Cycuria, Orbem, Carina Biotech, TRIMT, and others.
2. Patent Sale / Transfer Revenue: BayPAT commercializes IP through outright patent purchase and transfer agreements with corporate entities. Notable transactions include patent sales to Kyocera (2025), Cycuria (2024), Linde (2024), Evonik (2022), Reactive Robotics (2022), Bitflux (2017), and E.ON Energy Projects (2019). Revenue includes upfront payments and potentially milestone/royalty components.
3. Technology Transfer Services: BayPAT provides full-service technology management including invention evaluation, patent prosecution, market analysis, commercialization strategy, and contract negotiation for Bavarian universities and research institutes. Revenue supports operations through public funding under the BayFIA umbrella and service fees from client institutions.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Bayerische Patentallianz GmbH (BayPAT) is the central technology transfer agency for Bavarian universities, universities of applied sciences, and research institutes. The company evaluates inventions, prosecutes and manages patents, and commercializes technologies through exclusive and non-exclusive license agreements as well as outright patent sale transactions with industry partners. Its offering spans both Life Sciences (cardiovascular, oncology, neurology, immunology, infectious diseases, medical devices, biotechnology) and Physical Sciences (automotive, electrical engineering, energy and environment, IT/communication, materials, measurement technology, mechanical engineering).

Product overview

Bayerische Patentallianz GmbH (BayPAT) operates as a central technology transfer agency providing full-service intellectual property management and commercialization services. The organization combines research excellence from 28 Bavarian universities, universities of applied sciences, and research institutes, commercializing novel technologies in life sciences and physical sciences. The core offerings include Technology Transfer Services connecting research with industry, IP Management for patent portfolios, and IP Licensing for commercialization. Additional service modules cover support for Inventors, Industry clients, Start-ups, and WIPANO applicants. The technology portfolio spans multiple domains: Life Sciences technologies include Cardiovascular, Dermatology, Diagnostics/Biomarker, Drug Delivery, Gastroenterology, Immunology, Infectious Diseases, Medical Devices, Metabolic Disorders, Neurology/CNS, Oncology, Biotechnology, and Urogenital areas; Physical Sciences technologies cover Automotive, Electrical Engineering, Energy and Environment, IT and Communication, Material, Measurement Technology, and Mechanical Engineering.

Differentiator

Problem solved

Functional benefit

Products and services

• Technology Transfer Services

Quantifiable outcome

• 1,100 patents granted since 2007, with approximately 150 technology offers in portfolio
• +2 more outcomes

Named customers16 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Partnerships

23 partnerships are on record, tiered core and minor.

• KyoceracoreOEM/ Whitelabel/ Licensing Partner · 25 September 2025BayPAT signed a patent purchase agreement with Kyocera (announced September 2025). Details of the technology area were not specified in the available sources but represents an ongoing commercial relationship between BayPAT and the Japanese technology company.
• Cycuria GmbHcoreOEM/ Whitelabel/ Licensing Partner · 19 December 2024BayPAT entered a patent purchase agreement with Cycuria covering a patent portfolio for leukemia therapy technology developed by scientists at TUM Klinikum rechts der Isar (MRI-TUM). The technology covers a human cytokine that specifically induces cell death and differentiation of leukemic tumor cells and leukemic stem cells (LSCs) for treatment of Acute Myeloid Leukemia (AML).
• LindecoreOEM/ Whitelabel/ Licensing Partner · 28 October 2024BayPAT signed multiple patent purchase agreements with Linde (announced October 2024) for undisclosed technology in the industrial gases / energy sector.
• PROvendis GmbHcoreStrategic or Co-development Partner · 12 March 2024PROvendis and BayPAT formed a strategic alliance in technology transfer (PROvendis und BayPAT: Strategische Allianz im Technologietransfer). The alliance aims to strengthen cooperation between the two technology transfer organizations and enhance cross-regional IP commercialization services for German universities and industry.
• TreesenseminorOEM/ Whitelabel/ Licensing Partner · 7 September 2023BayPAT license agreement with Treesense enables smarter irrigation of trees through an intelligent tree watering technology.
• Dualyx NVcoreOEM/ Whitelabel/ Licensing Partner · 25 May 2023BayPAT licensee Dualyx NV raised EUR 40 million to progress Treg therapies for autoimmune diseases into the clinic. Dualyx is developing therapies derived from BayPAT-licensed IP.
• EvonikcoreOEM/ Whitelabel/ Licensing Partner · 5 December 2022BayPAT completed a patent purchase agreement with Evonik for undisclosed technology (announced December 2022).
• Reactive RoboticscoreOEM/ Whitelabel/ Licensing Partner · 6 July 2022BayPAT signed a new patent purchase agreement with Munich-based MedTech company Reactive Robotics for undisclosed medical robotics technology.
• RecardiocoreOEM/ Whitelabel/ Licensing Partner · 20 June 2022BayPAT licensee Recardio reached agreement with the FDA on pivotal Phase 3 trial design for Dutogliptin for regenerative post-myocardial infarction treatment. Recardio was already in Phase 2 clinical studies in Europe and the USA for the same compound.
• OrbemcoreOEM/ Whitelabel/ Licensing Partner · 26 January 2022BayPAT entered an exclusive license agreement with Orbem for ORBEM GENUS, a non-invasive method for sex determination in hen's eggs using magnetic resonance imaging and artificial intelligence, developed at TUM.
• Carina BiotechcoreOEM/ Whitelabel/ Licensing Partner · 15 December 2021BayPAT entered an exclusive license agreement with Carina Biotech (date: December 15, 2021). Details of the technology area were not specified.
• BIO Deutschland e.V.minorOthers · 12 October 2021BayPAT contributed a guest article to the BIO Deutschland Jubiläumsbuch (anniversary publication). BIO Deutschland e.V. is an independent biotechnology organization representing member interests at national, European, and global levels. BayPAT management participates in the association's activities.
• CadamiminorOEM/ Whitelabel/ Licensing Partner · 29 July 2021BayPAT concluded a licensing contract with Cadami (July 29, 2021). Technology area not specified in available sources.
• TRIMTminorOEM/ Whitelabel/ Licensing Partner · 1 June 2021BayPAT entered an exclusive license agreement with TRIMT (June 1, 2021). Technology area not specified in available sources.
• E.ON Energy Projects GmbHcoreOEM/ Whitelabel/ Licensing Partner · 13 May 2019BayPAT completed a patent sale and transfer agreement with E.ON Energy Projects GmbH for a technology for efficiency improvement and flexibility enhancement of gas-and-steam turbine combined cycle power plants with cogeneration, developed at TUM's Institute for Energy Systems.
• Blue Earth DiagnosticscoreOEM/ Whitelabel/ Licensing Partner · 10 May 2018Blue Earth Diagnostics signed a sub-license and option agreement with Scintomics (BayPAT's licensee) for worldwide exclusive rights to rhPSMA-targeted radiohybrid agents for prostate cancer imaging and an exclusive option for therapeutic applications. BayPAT was involved in negotiations as Scintomics' licensor.
• Scintomics GmbHcoreOEM/ Whitelabel/ Licensing Partner · 7 December 2017BayPAT entered three license agreements (triple deal) with Scintomics for innovative PSMA-ligands for prostate cancer imaging (radiohybrid platform) and next-generation CXCR4 radioligands for diagnostic and therapeutic applications in lymphoproliferative and cardiovascular diseases. Scintomics subsequently sublicensed the rhPSMA technology to Blue Earth Diagnostics with BayPAT's involvement in negotiations.
• BayFIA (Bayerische Forschungs- und Innovationsagentur)coreOthersBayPAT operates under the umbrella of the Bavarian Research and Innovation Agency (BayFIA). BayFIA serves as the parent organization providing strategic direction and coordination for BayPAT and other Bavarian innovation support agencies.
• Bayern InnovativminorStrategic or Co-development PartnerBayern Innovativ is a Bavarian innovation network partner. BayPAT collaborates with Bayern Innovativ to connect university research with industry partners and support technology-based economic development in Bavaria.
• Bayerische ForschungsstiftungminorStrategic or Co-development PartnerBayerische Forschungsstiftung (Bavarian Research Foundation) is a partner organization supporting BayPAT's network of research and innovation collaboration in Bavaria.
• Bayerische ForschungsallianzminorStrategic or Co-development PartnerBayerische Forschungsallianz (BayFOR) is a partner organization in BayPAT's network supporting cross-institutional research collaboration and technology transfer.
• Technologie AllianzminorChannel Partner/ Reseller/ DistributorTechnologie Allianz is a technology transfer network partner that helps BayPAT reach broader industry audiences for its technology offers.
• Bio MminorStrategic or Co-development PartnerBio M is a Bavarian biotech cluster organization (Bio-M cluster management GmbH) and BayPAT network partner supporting biotechnology transfer and startup activities.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PROvendis GmbH: Central technology transfer office for North Rhine-Westphalia's universities, with a direct mandate paralleling BayPAT's in Bavaria: evaluating invention disclosures, patenting IP, and licensing to industry. PROvendis and BayPAT entered a 2024 strategic alliance, making them the two leading comparable German university TLOs.
• Ascenion GmbH: Life-science-focused technology transfer partner for German public research institutions (including Helmholtz and others). Ascenion's biotech/medtech focus, spin-off support (e.g., leading to several clinical-stage assets), and shared German public-research mission make it a strong direct peer to BayPAT's Life Sciences practice.
• Max Planck Innovation GmbH: The technology transfer arm of the Max Planck Society (~86 institutes), managing invention disclosures, patent prosecution, and licensing across German basic-research institutions. Same university-to-industry commercialization model as BayPAT, with the same revenue mix (licensing royalties, patent sales, spin-offs) but serving a different research society.

Broad incumbents

• IP Group plc: UK-listed IP commercialization firm that funds and spins out research from universities (Oxford, Cambridge, Bristol, etc.) by taking equity/license stakes and sharing royalties. Listed, capital-markets-financed TLO model that contrasts with BayPAT's public-sector ownership; relevant for cross-model benchmarking.
• Helmholtz Association (Technology Transfer): Germany's largest scientific organization (18 research centers with EUR 5+ billion annual budget), with technology-transfer offices that license and spin out inventions across energy, health, and materials. Comparable in scale-of-pipeline and public-research mandate, though handled across multiple member centers rather than a single TLO.
• Fraunhofer-Gesellschaft (Patent & Licensing): Germany's largest applied-research organization, operating its own IP and licensing infrastructure across 75+ institutes. While Fraunhofer's applied-research focus differs from BayPAT's basic-science mandate, the licensing business model (invention evaluation, patent prosecution, licensing and spin-offs) directly parallels BayPAT's Physical Sciences offering at scale.

Others

• TransferAllianz: Network of ~30 German technology-transfer offices (university and non-university) that share best practices, run joint industry outreach, and co-market IP. BayPAT is a likely member; TransferAllianz is an ecosystem-level peer rather than a competitor, aggregating many German TLOs of which BayPAT is one of the largest.

Regional players

• Columbia Technology Ventures (Columbia University): US university tech transfer office that evaluates invention disclosures, prosecutes patents, and licenses university IP across life sciences and physical sciences from a top US research institution. A US analog of BayPAT's full-service TLO model, illustrating how a leading research university operationally commercializes its IP.
• Imperial College Innovations (now Imperial College Tech Transfer): UK university technology transfer operation for Imperial College London, one of Europe's leading research institutions. Closest UK analog in pipeline quality and a peer in the European university TLO landscape, though operating under a different national funding and ownership model.
• Octoplus (Leiden University tech transfer): Netherlands-based tech transfer office serving Leiden University and partner research institutions, with the same university-mandated IP commercialization focus. Smaller in scale than BayPAT but operationally comparable across disclosure assessment, patent prosecution, and license negotiation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/transferblog
• LinkedInlinkedin.com/company/bayerische-patentallianz-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bayerische Patentallianz